Medistim ASA (FRA:MD1)
€ 12.15 -0.25 (-2.02%) Market Cap: 226.29 Mil Enterprise Value: 216.00 Mil PE Ratio: 23.78 PB Ratio: 5.97 GF Score: 90/100

Q4 2022 Medistim ASA Earnings Call Transcript

Mar 01, 2023 / 07:00AM GMT
Release Date Price: €20.95 (-3.68%)
Kari Krogstad
Medistim ASA - President & CEO

Good morning. This is Grey Oslo reporting in. So welcome to Medistim's first-quarter 2023 presentation. And my name is Kari Krogstad. And together with CFO, Thomas Jakobsen, we will take you through the quarterly results. And we will follow the same agenda that we are used to going through starting with the highlights.

And we're starting with the quarterly sales of NOK129.3 million in revenue this quarter. And this is the second-best quarter we have delivered, only beaten by the fourth quarter last year. But as we see here, the majority of the contribution to growth comes from currency. If we look at the growth in Norwegian currency, we see 15% growth in sales of our own products. And we can also see that all the product categories and marketing segment categories are contributing to this growth.

When it comes to the third party, those are down this quarter by 4.5%. Then if we look at the currency neutral growth, we see that this is a very modest 1.2% in total. When it comes to our currency-neutral growth for our own products, that is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot